Pharmacokinetics Safety and Acceptability of DRV/r for Children Living With HIV

NCT06139796 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped Study not started as the IMP is re-worked by the manufacturer

Conditions

HIV Infections

Interventions

DRUG: DRV/r FDC (120/20mg)

Sponsor

PENTA Foundation

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]